Discovering a new world of therapeutics

The therapeutic potential of the human transcriptome, the set of all RNAs transcribed from DNA, remains largely unexplored. By harnessing new insights into RNA structure and dynamics, Arrakis is opening the transcriptome to therapy by small-molecule medicines to treat patients not cured by today’s medicines. We aim to unlock the therapeutic potential of deeply researched, valuable targets and to identify new disease intervention points that may be uniquely addressed with RNA-targeted small molecules (rSMs).

Data‐driven Guideposts for Targeting RNA
Aug 01, 2018
Chris Burge, PhD
A Transition at Arrakis
Jun 26, 2018
Michael Gilman, PhD
Targeting RNA – Lessons Learned from Oligos
May 08, 2018
James Barsoum, PhD
Back to Top